| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 1,036,484 | 1,068,913 | 1,092,964 | 993,444 | | Cost of Revenue | 98,197 | 101,161 | 107,493 | 92,401 | | | Gross Profit | 938,287 | 967,752 | 985,471 | 901,043 | | | Operating Expenses | | Research Development | 279,478 | 292,767 | 268,800 | 252,259 | | Selling General and Administrative | 264,603 | 132,595 | 276,357 | 300,524 | | Non Recurring |
-
| (9,242) |
-
|
-
| | Others | 89,248 | 226,672 | 94,464 | 51,463 | | | | Total Operating Expenses |
-
| 642,792 |
-
|
-
| | | | Operating Income or Loss | 304,958 | 324,960 | 345,850 | 296,797 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 6,846 | (77,650) | (15,725) | 28,337 | | Earnings Before Interest And Taxes | 311,804 | 252,510 | 329,125 | 320,934 | | Interest Expense |
-
| (37,600) | 8,000 | 29,600 | | Income Before Tax | 311,804 | 290,110 | 321,125 | 291,334 | | Income Tax Expense | 65,225 | 83,456 | 114,337 | 84,706 | | Minority Interest |
-
| 5,200 | (1,000) | (4,200) | | | | Net Income From Continuing Ops | 246,579 | 206,654 | 206,788 | 206,628 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 246,579 | 206,654 | 206,788 | 206,628 | | Preferred Stock And Other Adjustments | (2,592) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $243,987 | $206,654 | $206,788 | $206,628 |
|
0.45% Nasdaq 
0.20%
Income Statement
